MTOR and non-small cell lung carcinoma: We pathologically analyzed p38 and mTOR activation via a similar appraisal strategy in a case-to-case manner, and found synchronized changes in Zscan4 expression and p38/mTOR activation in the tumour stroma of NSCLC patients (Fig. 2f).